PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 12, 1983Acta Medica Scandinavica40 citations

Coxsackie B Virus Antibodies in Myocardial Infarction

View Full Paper
JNJ NikoskelainenJKJ. L. KalliomäkiKLK Lapinleimu

Structured PICO

Is Coxsackie B virus infection associated with acute myocardial infarction?

P
Population
97 patients, comprising 59 with acute myocardial infarction and 38 control patients
I
Intervention
Coxsackie B virus infection (assessed via Coxsackie B1-5 virus antibodies)
C
Comparator
Control patients without acute myocardial infarction
O
Outcome
Fourfold or higher antibody increase in paired serum samples against Coxsackie B1-5 virusessurrogate

Coxsackie B virus infection may have a causal role or act as a triggering factor in acute myocardial infarction.

Abstract

Evidence for the association between Coxsackie B virus infections and myocardial infarction was studied in a prospective follow-up examination. Using the micro neutralization test, 9 (15%) of 59 patients with acute myocardial infarction and 1 (2.6%) of 38 control patients showed a fourfold, or higher, antibody increase in paired serum samples against Coxsackie B1-5 viruses. This difference is significant (p less than or equal to 0.05). None of the patients or controls revealed symptoms of a viral infection during the blood sampling. Virus isolation from throat and feces was negative in all patients and controls. This finding agrees with some previous studies suggesting that the Coxsackie B group may in some cases have a causal role in myocardial infarction, or may act as a triggering factor.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nikoskelainen et al. (1983) studied this question.

synapsesocial.com/papers/6a1fc863fbbc844d2a9899ddhttps://doi.org/10.1111/j.0954-6820.1983.tb08566.x
Ask AI
Helpful
Bookmark
Share
View Full Paper